Xyrem (X)
OMC-SXB-23
Approved small_molecule completed
Quick answer
Xyrem (X) for Obstructive Sleep Apnea Syndrome is a Approved program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Obstructive Sleep Apnea Syndrome
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed